| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1772.)
© 2002 American Heart Association, Inc.
Brief Rapid Communications |
From the Clinic of Diagnostic Radiology, University of Technology Aachen, Germany.
Correspondence to Arno Buecker, MD, Clinic of Diagnostic Radiology, Pauwelsstr 30, 52057 Aachen, Germany. E-mail buecker{at}rad.rwth-aachen.de
Background Metallic stents cause susceptibility and radiofrequency artifacts on MR images, which, up to now, have not allowed for complete visualization of the stent lumen by MR angiography. The aim of this study was to investigate the potential of a new dedicated renal MRI stent for artifact-free in-stent lumen visualization in vitro and in a swine model.
Methods and Results In vitro investigations were performed with prototypes of balloon-expandable Aachen Resonance Renal MRI Stents dilated to diameters of 3 to 6 mm and placed in an aqueous gadolinium solution (1:25). Phase-contrast and contrast-enhanced T1-weighted gradient echo images were acquired. Renal MRI stents (n=12) were deployed in the renal arteries of 6 pigs. Renal arteries were examined with phase-contrast angiography and with flow measurements before and after stent placement in the stented area, respectively. Additionally, a contrast-enhanced, T1-weighted, spoiled-gradient echo sequence after administration of 0.2 mmol gadolinium-DTPA/kg body weight was performed after stent placement. The visibility of artifacts was analyzed on in vitro and in vivo images by two investigators who knew the stent positions. Stent positions were determined visually (in vitro) or by x-ray angiography (animal experiments). No artifacts were detected independent of the applied imaging sequence and the stent orientation to the main magnetic field.
Conclusion The examined prototypes of fully MR-compatible MRI stents allow artifact-free visualization of the stent lumen with phase-contrast and contrast-enhanced T1-weighted angiography, as well as phase-contrast flow measurements in the stented area.
Key Words: magnetic resonance imaging angiography stents
This article has been cited by other articles:
![]() |
R. W. Huegli, M. Aschwanden, G. Bongartz, K. Jaeger, H.-G. Heidecker, C. Thalhammer, A.-C. Schulte, C. Hashagen, A. L. Jacob, and D. Bilecen Intraarterial MR Angiography and DSA in Patients with Peripheral Arterial Occlusive Disease: Prospective Comparison Radiology, June 1, 2006; 239(3): 901 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Martin, D. A. Saloner, T. P. L. Roberts, H. Roberts, O. M. Weber, W. Dillon, S. Cullen, V. Halbach, C. F. Dowd, and R. T. Higashida Carotid Stent Delivery in an XMR Suite: Immediate Assessment of the Physiologic Impact of Extracranial Revascularization AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 531 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Spuentrup, A. Ruebben, A. Mahnken, M. Stuber, C. Kolker, T. H. Nguyen, R. W. Gunther, and A. Buecker Artifact-Free Coronary Magnetic Resonance Angiography and Coronary Vessel Wall Imaging in the Presence of a New, Metallic, Coronary Magnetic Resonance Imaging Stent Circulation, March 1, 2005; 111(8): 1019 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Hagspiel, D. A. Leung, K. R. Nandalur, J. F. Angle, H. S. Dulai, D. J. Spinosa, A. H. Matsumoto, J. M. Christopher, H. Ahmed, and S. S. Berr Contrast-Enhanced MR Angiography at 1.5 T After Implantation of Platinum Stents: In Vitro and In Vivo Comparison with Conventional Stent Designs Am. J. Roentgenol., January 1, 2005; 184(1): 288 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
S K Prasad and D J Pennell Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices Heart, November 1, 2004; 90(11): 1241 - 1244. [Full Text] [PDF] |
||||
![]() |
R. M. Botnar, A. Buecker, A. J. Wiethoff, E. C. Parsons Jr, M. Katoh, G. Katsimaglis, R. M. Weisskoff, R. B. Lauffer, P. B. Graham, R. W. Gunther, et al. In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent Circulation, September 14, 2004; 110(11): 1463 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Wacker, R. M. Maes, J. A. Jesberger, S. G. Nour, J. L. Duerk, and J. S. Lewin MR Imaging-Guided Vascular Procedures Using CO2 as a Contrast Agent Am. J. Roentgenol., August 1, 2003; 181(2): 485 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Spuentrup, A. Ruebben, M. Stuber, R. W. Gunther, and A. Buecker Metallic Renal Artery MR Imaging Stent: Artifact-free Lumen Visualization with Projection and Standard Renal MR Angiography Radiology, June 1, 2003; 227(3): 897 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Buecker, E. Spuentrup, R. Grabitz, F. Freudenthal, E. G. Muehler, T. Schaeffter, J. J. van Vaals, and R. W. Gunther Magnetic Resonance-Guided Placement of Atrial Septal Closure Device in Animal Model of Patent Foramen Ovale Circulation, July 23, 2002; 106(4): 511 - 515. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |